JP2019504102A5 - - Google Patents

Download PDF

Info

Publication number
JP2019504102A5
JP2019504102A5 JP2018540796A JP2018540796A JP2019504102A5 JP 2019504102 A5 JP2019504102 A5 JP 2019504102A5 JP 2018540796 A JP2018540796 A JP 2018540796A JP 2018540796 A JP2018540796 A JP 2018540796A JP 2019504102 A5 JP2019504102 A5 JP 2019504102A5
Authority
JP
Japan
Prior art keywords
compound
methyl
imidazo
pharmaceutical composition
propyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018540796A
Other languages
English (en)
Japanese (ja)
Other versions
JP7065030B2 (ja
JP2019504102A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/052201 external-priority patent/WO2017134133A1/en
Publication of JP2019504102A publication Critical patent/JP2019504102A/ja
Publication of JP2019504102A5 publication Critical patent/JP2019504102A5/ja
Application granted granted Critical
Publication of JP7065030B2 publication Critical patent/JP7065030B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018540796A 2016-02-03 2017-02-02 Ｒｓｖの処置のための組合せ製品 Expired - Fee Related JP7065030B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16154035.6 2016-02-03
EP16154035 2016-02-03
PCT/EP2017/052201 WO2017134133A1 (en) 2016-02-03 2017-02-02 Combination products for the treatment of rsv

Publications (3)

Publication Number Publication Date
JP2019504102A JP2019504102A (ja) 2019-02-14
JP2019504102A5 true JP2019504102A5 (enExample) 2020-03-12
JP7065030B2 JP7065030B2 (ja) 2022-05-11

Family

ID=55304886

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018540796A Expired - Fee Related JP7065030B2 (ja) 2016-02-03 2017-02-02 Ｒｓｖの処置のための組合せ製品

Country Status (19)

Country Link
US (1) US10363253B2 (enExample)
EP (2) EP3411028B1 (enExample)
JP (1) JP7065030B2 (enExample)
KR (1) KR20180108598A (enExample)
CN (2) CN108601774B (enExample)
AU (2) AU2017214246B2 (enExample)
BR (1) BR112018014958A2 (enExample)
CA (1) CA3006488A1 (enExample)
CL (3) CL2018001808A1 (enExample)
EA (3) EA202092250A1 (enExample)
ES (1) ES2877808T3 (enExample)
IL (2) IL259669B (enExample)
MX (2) MX2020012592A (enExample)
MY (1) MY197217A (enExample)
PH (2) PH12020551598B1 (enExample)
SG (1) SG11201806581TA (enExample)
UA (1) UA124099C2 (enExample)
WO (1) WO2017134133A1 (enExample)
ZA (1) ZA201805205B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201701184WA (en) 2014-10-10 2017-03-30 Pulmocide Ltd Novel 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative
WO2016097761A1 (en) 2014-12-18 2016-06-23 Pulmocide Limited 4,5-dihydro-6h-thieno[3,2-d]benzazepine derivatives and their use to treat respiratory syncytial virus (rsv) infections
WO2017175000A1 (en) 2016-04-08 2017-10-12 Pulmocide Limited Compounds
TW201936193A (zh) * 2017-12-05 2019-09-16 愛爾蘭商健生科學愛爾蘭無限公司 使用組合產品治療ｒｓｖ
MX2022005257A (es) * 2019-10-30 2022-06-09 Janssen Sciences Ireland Unlimited Co Sintesis de 3-({5-cloro-1-[3-(metilsulfonil)propil]-1h-indol-2-il} metil)-1-(2,2,2-trifluoroetil)-1,3-dihidro-2h-imidazo[4,5-c]pirid in-2-ona.
CN114014856B (zh) * 2021-11-26 2023-12-22 嘉兴安谛康生物科技有限公司 作为呼吸道合胞病毒抗病毒剂的咪唑并吡啶类衍生物
CN116077494A (zh) * 2023-01-11 2023-05-09 黑龙江中医药大学 一种治疗呼吸道合胞病毒的药物组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI515187B (zh) 2010-12-16 2016-01-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之吲哚類
CN110590916A (zh) * 2013-04-25 2019-12-20 扬森疫苗与预防公司 稳定化的可溶性融合前rsv f多肽
HK1225716A1 (zh) * 2013-08-21 2017-09-15 Alios Biopharma, Inc. 抗病毒化合物
SG11201701184WA (en) 2014-10-10 2017-03-30 Pulmocide Ltd Novel 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative

Similar Documents

Publication Publication Date Title
JP2019504102A5 (enExample)
AU2015296322B2 (en) 2-amino-pyrido[2,3-d]pyrimidin-7(8h)-one derivatives as CDK inhibitors and uses thereof
PH12018501649A1 (en) Combination products for the treatment of rsv
TWI248932B (en) Respiratory syncytial virus replication inhibitors
AU2013345107B2 (en) Heteroaromatic compounds as PI3 kinase modulators and methods of use
TW201011021A (en) Imidazopyridin-2-one derivative
JP2025535045A (ja) Ｋｒａｓ ｇ１２ｃ変異タンパク質の複素環阻害剤及びその使用
AU2014363894C1 (en) Tropomyosin-related kinase (Trk) inhibitors
EP3875078A1 (en) Compounds for the treatment of covid-19
BR112019019555A2 (pt) composto de fórmula i, composição farmacêutica, método de inibição de hpk1, método para melhorar uma resposta imune, método para tratar um distúrbio e uso do composto
KR20180030199A (ko) 콜로니 자극 인자-1 수용체(csf-1r) 저해제
JP2016538316A5 (enExample)
JP2014513139A5 (enExample)
JP6389829B2 (ja) Ｐｉ３キナーゼモジュレータとしてのヘテロ芳香族化合物、及びその使用方法
JP2001097889A (ja) Ｃｒｆアンタゴニストおよび関連組成物の使用
JP2014503544A5 (enExample)
TW200538128A (en) Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists
EP1177797A1 (en) Novel use
WO2022051568A1 (en) Substituted 4-piperidinyl-pyrrolo[2,3-b]pyridines and related compounds and their use in treating medical conditions
RU2019108259A (ru) Комбинированная терапия для лечения гепатоцеллюлярной карциномы
JP2016517877A5 (enExample)
WO2011096490A1 (ja) イミダゾピリジン－２－オン誘導体
WO2025172573A1 (en) Combinations of par2 inhibitors and immune checkpoint inhibitors for the treatment of cancer
RU2022104462A (ru) Фармацевтические соединения
TH1901000005A (th) อนุพันธ์อิมิดาโซ[1,2-a]ไพริดีน, วิธีการเตรียมสิ่งเดียวกัน, และการใช้งานของสิ่งนั้น (IMIDAZO[1,2-a]PYRIDINE DERIVATIVES, METHODS FOR PREPARING THE SAME AND USE THEREOF)